Back to today’s briefing

Story perspectives

Revolutionary Oral Antiviral Achieves 100% Ebola Survival Rate

3/17/2025

46 10

Summary

Story summary

Researchers at the University of Texas have made a groundbreaking advancement with obeldesivir, an oral antiviral that could revolutionize Ebola treatment. In trials, it boasted a remarkable 100% survival rate in rhesus monkeys and 80% in cynomolgus monkeys. This innovative approach promises easier administration and storage, enhancing our ability to respond to future outbreaks.

1 of 1

Story summary

Researchers at the University of Texas have made a groundbreaking advancement with obeldesivir, an oral antiviral that could revolutionize Ebola treatment. In trials, it boasted a remarkable 100% survival rate in rhesus monkeys and 80% in cynomolgus monkeys. This innovative approach promises easier administration and storage, enhancing our ability to respond to future outbreaks.